Drug ID:   | NPD6889 |
Drug Name:   | |
Molecular Formula:   | C27H37N9O7S3 |
Canonical SMILES:   | CN(CCn1nnnc1SCC1=C(C(=O)OC(OC(=O)OC2CCCCC2)C)N2[C@H](SC1)[C@@H](C2=O)N=C(Cc1csc(=N)[nH]1)O)C |
Standard InCHI:   | InChI=1S/C27H37N9O7S3/c1-15(42-27(40)43-18-7-5-4-6-8-18)41-24(39)21-16(13-46-26-31-32-33-35(26)10-9-34(2)3)12-44-23-20(22(38)36(21)23)30-19(37)11-17-14-45-25(28)29-17/h14-15,18,20,23H,4-13H2,1-3H3,(H2,28,29)(H,30,37)/t15?,20-,23-/m1/s1 |
Standard InCHIKey:   | VVFDMWZLBPUKTD-ZKRNHDOASA-N |
Max Developmental Stage:   | Approved |
Max Developmental Stage Source:   | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
TTD   | DNAP001454 |
DrugBank   | |
ChEMBL   | |
IUPHAR/BPS   | |
PharmaGKB   | |
KEGG Drug   | |
PubChem CID   | 175647 |
ChEBI   | |
CAS Number   |
Molecular Weight   | 695.20 |
ALogP   | 0.0614 |
MLogP   | 2.34 |
XLogP   | 2.959 |
HDA   | 16 |
HBD   | 3 |
Rotatable Bonds   | 20 |
TPSA   | 273.35 |
RO5 Violation   | 2 |